Roka Bioscience Prominex Developing Rapid Point-of-Care MDx Using Novel Detection Tech Premium The technology works directly from clinical samples and can potentially be multiplexed to detect tens of targets, according to the firm. Roka Bioscience Sells Assets for $17.5M, Will Likely Liquidate The sale of assets to the Institute for Environmental Health comes after an extensive review of strategic alternatives for Roka, the company said. Roka Bio Q1 Revenues Rise 25 Percent Revenue growth was driven by a 26 percent increase in the number of pathogen detection tests sold. The total number of placed Atlas instruments ticked up to 54. Roka Bioscience Q4 Revenues Up 27 Percent The company said it had 53 of its Atlas molecular diagnostic systems placed with customers under commercial agreements as of the end of 2016. Roka Bioscience Q3 Revenues Up 27 Percent The company attributed the revenue growth to an increased number of its Atlas molecular pathogen detection instruments placed with customers. Oct 11, 2016 Roka Bioscience Plans 1-for-10 Reverse Stock Split Sep 16, 2016 Roka Bioscience Plans to Raise $22.5M in Private Placement Aug 5, 2016 Roka Bioscience Q2 Revenues Up 20 Percent May 4, 2016 Roka Bioscience Q1 Revenues Grow 7 Percent Mar 4, 2016 Roka Bioscience Q4 Revenues Rise 7 Percent Dec 15, 2015 MBio Dx, Roka Bio Ink Food Safety Product Development Deal Nov 11, 2015 Roka Bioscience Reports Flat Q3 Revenues Sep 23, 2015 Roka Bioscience Targets $100M Public Offering With Shelf Registration Aug 13, 2015 Roka Bio Revenues Grow 7 Percent in Q2 May 8, 2015 Roka Bioscience Posts 82 Percent Rise in Q1 Revenues Mar 26, 2015 Roka Bio Reports Doubling of Q4 Revenues Nov 6, 2014 Roka Bioscience Posts Jump in Q3 Revenues; Falls Short of Estimates Aug 15, 2014 In Brief This Week: Roka Bioscience, Hologic; Almac; Eurofins; Quest Diagnostics; Interleukin; and More Aug 11, 2014 Roka Bio Q2 Revenues More than Double; Leerink Initiates Coverage with Outperform Rating Jul 17, 2014 Roka Goes Public in $60M Stock Offering Jul 8, 2014 UPDATE: Roka Eyes Net Proceeds of $78M from Planned IPO May 22, 2014 Roka Bioscience Joins Growing List of MDx Firms Seeking an IPO Jan 20, 2012 In Brief This Week: Complete Genomics; MOgene, Fluidigm; Roka Bioscience; Silicon Kinetics; Precision Biosciences; IDBS Jan 12, 2012 Roka Bioscience Secures $47.5M Financing to Commercialize Food Testing Platform Premium Jan 6, 2012 Roka Bioscience Closes on $27.5M of Targeted $47.5M in Series D Round Load More Breaking News Ancient DNA Analysis Highlights Three Ancestral Populations in Japan FDA Warns of Potential False Positives With Abbott SARS-CoV-2 Molecular Tests New Products Posted to GenomeWeb: Oxford Nanopore, Beckman Coulter, Thermo Fisher Scientific, More People in the News: New Appointments at Sema4, NHGRI, Dante Labs, Ancestry, More Thermo Fisher Scientific Expects 12 Percent Revenue Growth in 2022 In Brief This Week: Myriad Genetics, Danaher, Co-Diagnostics, and More The Scan For Those Thick Tiger Stripes Tigers in India with thick stripes harbor a genetic change, as Gizmodo reports. High GABA Tomatoes The Japan News reports that genome-edited tomatoes with higher GABA levels are now for sale in Japan. Approach for Inclusivity and Diversity A National Human Genome Research Institute team calls for the field to "adopt diversity as an ethos." Science Papers on Tumors Immune System Evasion; Drivers of Genomic Instability, Inflammation In Science this week: study of how tumors evade the adaptive immune system, and more.